Vice Chair (2009), Founder, Chairman, and Chief Executive Officer (1988 - 2009), Granite Broadcasting Corporation Chief Operating Officer ( COO ), Corporate Finance Department (1980 - 1988), Vice President, Investment Banking (1976 - 1988); joined the company in 1971, Goldman, Sachs & Co. Key Skills and Experience: CEO and Public Company Management, Corporate Governance, Finance, Accounting, and Capital Markets, Global Business, and Strategy and M&A Experience developed during his various executive roles, more specifically during his years at Goldman Sachs, where he engaged in public and private financing and advised mergers and acquisitions ( M&A ) transactions for publicly traded and privately owned companies, and further advanced through his founding and leadership of Granite Broadcasting Human Capital Management and Information Security Experience gained while serving as the COO of the Corporate Finance Department of the Investment Banking Division of Goldman Sachs where he was responsible for the management of the department including building the operational infrastructure information technology ( IT ), document production, training, and recruiting while the department of over 150 investment banking professionals was experiencing significant staffing growth in response to a dramatic increase in the volume of transactions they were handling Mr. Cornwell also brings Healthcare Industry and Legal and Regulatory Oversight Experience to the Board Former Public Company Boards: American International Group, Inc. (NYSE: AIG) (2011 - 2024), Director, and most recently member of the Audit and Nominating and Corporate Governance Committees; also previously Chairman of the Compensation and Management Resources Committee Natura & Co Holding S.A. (NYSE: NTCO) (2020 - 2023), Director and most recently member of the Corporate Governance Committee Avon Products, Inc. (2002 - 2020 when acquired by Natura), Director and Lead Independent Director, and most recently Chair of the Finance Committee and member of the Audit and Nominating and Governance Committees Pfizer, Inc. (NYSE: PFE) ( Pfizer ) (1997 - the closing of the combination of Mylan N.V. ( Mylan ) with Pfizer s Upjohn business (the Upjohn business ) through a Reverse Morris Trust transaction (the Combination ) in 2020), Director, and most recently Chair of the Regulatory and Compliance Committee and member of the Governance and Sustainability Committee; also, previously Chair of the Audit Committee Other Organizations: Vice Chairman and Lead Director of the Board of Directors, Blue Meridian Partners , a partnership of philanthropists that invests in strategies to impact social problems confronting young people and families in poverty Board of Trustees, Occidental College , and Vice Chair of the Investment Committee Advisory, Orca Biosystems, Inc. , a private biotechnology company developing high-precision cell therapies for the treatment of cancer and autoimmune diseases